Forschung & Innovation
Publikationen

The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells.

#2016

#Oncotarget

PMU Autor*innen
Christian Reinhard Mayr, Andrej Wagner, Daniela Bruckner, Martin Jakab, Frieder Berr, Daniel Neureiter, Tobias Kiesslich

Alle Autor*innen
Christian Reinhard Mayr, Andrej Wagner, Magdalena Loeffelberger, Daniela Bruckner, Martin Jakab, Frieder Berr, Pietro Di Fazio, Matthias Ocker, Daniel Neureiter, Martin Pichler, Tobias Kiesslich

Fachzeitschrift
Oncotarget

Kurzfassung

Keywords

PROTEIN, IN-VITRO, EXPRESSION, STEM-CELLS, BREAST-CANCER, EXTRAHEPATIC CHOLANGIOCARCINOMA CELLS, HEPATOCELLULAR-CARCINOMA, ANTICANCER DRUGS, POOR-PROGNOSIS, POLYCOMB

Weitere Publikationen

#2026

#Originalarbeit

Xinxin Zhu, Yi Yang, Helen Wright, Lydia Gabriela Speyer, Marie Allitt, Ingrid Obsuth, Patrick Errington, Aja Louise Murray The association between social media use and mental health symptoms in middle adolescence, SUICIDE ATTEMPTS; SELF-HARM; adolescence; Counterfactual analysis; Emotional symptoms; Social media use;

#2026

#Abstrakt

Lara Sophie Bieler Therapeutic MSC-EV delivery and iNSC transplantation for spinal cord injury repair

#2026

#Originalarbeit

Fabrizio Rinaldi, Bruna Nucera, Sara Mariozzi, Eleonora Leuci, Arianna Bratti, Wolfgang Hitzl, Luigi Ferini-Strambi, Eugen Trinka, Kneginja Richter Impact of Chronotype-Based scheduling on sleep EEG in first seizure Patients

Zurück zur Übersicht

Paracelsus Medizinische Privatuniversität Forschung & Innovation Publikationen

The BMI1 inhibitor PTC-209 is a potential compound...